Clinical Trial Update: Study to Test GSK256073 in Patients With Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for GSK256073 in dyslipidemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• GSK256073

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dyslipidaemias, Dyslipidemias | Phase 2 | Status: COMPLETED | Results posted: 2017-09-21